West Paces Advisors’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-150
Closed -$16.5K 570
2024
Q4
$16.5K Hold
150
﹤0.01% 312
2024
Q3
$17K Hold
150
﹤0.01% 314
2024
Q2
$18.5K Hold
150
﹤0.01% 300
2024
Q1
$19.3K Hold
150
0.01% 310
2023
Q4
$18.5K Hold
150
0.01% 312
2023
Q3
$15.3K Hold
150
﹤0.01% 315
2023
Q2
$15.1K Sell
150
-140
-48% -$14K ﹤0.01% 332
2023
Q1
$29.8K Buy
+290
New +$31.2K 0.01% 267

Other funds holding IOSP

West Paces Advisors's IOSP Position: Q1 2025 in Review

West Paces Advisors sold out of Innospec (IOSP) in Q1 2025, closing a stake of 150 shares — an estimated $16.5K sold.

West Paces Advisors first reported a position in IOSP in Q1 2023 and held it in 8 quarters. The position peaked at $29.8K in Q1 2023. 272 funds tracked by Wall St. Rank hold IOSP as of Q1 2025.

  • West Paces Advisors reported no remaining Innospec position as of Q1 2025 after selling out during the quarter.
  • West Paces Advisors sold 150 Innospec shares in Q1 2025, an estimated $16.5K.
  • West Paces Advisors first reported a position in Innospec in Q1 2023 and held it in 8 quarters.
  • West Paces Advisors's Innospec position peaked at $29.8K in Q1 2023.
  • 272 funds tracked by Wall St. Rank held Innospec as of Q1 2025.

Based on West Paces Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.